An Expression of Concern from The Journal of Nutrition's Editorial Office about: High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial
- PMID: 33096557
- DOI: 10.1093/jn/nxaa342
An Expression of Concern from The Journal of Nutrition's Editorial Office about: High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial
Expression of concern for
-
High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial.J Nutr. 2018 Aug 1;148(8):1380-1386. doi: 10.1093/jn/nxy116. J Nutr. 2018. Retraction in: J Nutr. 2021 May 11;151(5):1362. doi: 10.1093/jn/nxab074. PMID: 29982544 Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources